These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. The treatment of advanced endometrial cancer with hydroxyprogesterone caproate. Reifenstein EC Gynecol Oncol; 1974 Aug; 2(2-3):377-414. PubMed ID: 4616884 [No Abstract] [Full Text] [Related]
26. [Treatment with high doses of progestational agents in endometrial adenocarcinoma]. Goisis M; Servida E; Goisis F Minerva Ginecol; 1976 Jan; 28(1):87-96. PubMed ID: 1256709 [No Abstract] [Full Text] [Related]
28. [Results of high dosage progesterone therapy in carcinoma corporis uteri]. Seewald HJ; Böhm W; Przesang R Zentralbl Gynakol; 1977; 99(7):392-5. PubMed ID: 868363 [TBL] [Abstract][Full Text] [Related]
29. [Regularities and paradoxes of endocrine dependence and hormonal therapy of endometrial cancer]. Bokhman IaV; Volkova AT; Chepik OF; Vishnevskiĭ AS Vopr Onkol; 1990; 36(11):1382-8. PubMed ID: 2281650 [No Abstract] [Full Text] [Related]
30. The histological changes produced in untreated adeno-carcinoma of the endometrium by a progestogen. Hudson CN; Stansfeld AG J Obstet Gynaecol Br Commonw; 1967 Jun; 74(3):442-4. PubMed ID: 6026619 [No Abstract] [Full Text] [Related]
31. Progestin therapy in lesions of the endometrium. Wentz WB Semin Oncol; 1985 Mar; 12(1 Suppl 1):23-7. PubMed ID: 3975648 [TBL] [Abstract][Full Text] [Related]
32. [Synthetic progestational hormones in high doses in adenocarcinoma of the endometrium. (Study of carbohydrate metabolism)]. Pasquinucci C Minerva Ginecol; 1970 Oct; 22(19):950-6. PubMed ID: 5516459 [No Abstract] [Full Text] [Related]
33. Treatment of advanced adenocarcinoma of the endometrium with melphalan, 5-fluorouracil, and medroxyprogesterone acetate: a preliminary study. Cohen CJ; Deppe G; Bruckner HW Obstet Gynecol; 1977 Oct; 50(4):415-7. PubMed ID: 904803 [TBL] [Abstract][Full Text] [Related]
34. [Intramitochondrial changes in adenocarcinoma cells of the uterine mucosa following progesterone therapy]. Szarvas Z Morphol Igazsagugyi Orv Sz; 1980 Apr; 20(2):81-7. PubMed ID: 7266506 [TBL] [Abstract][Full Text] [Related]
35. [Treatment of metastasizing carcinoma of the uterus with gestagens]. Engeler V Schweiz Med Wochenschr; 1971 Dec; 101(52):1906-9. PubMed ID: 5141283 [No Abstract] [Full Text] [Related]
36. [Chemotherapy and endocrine therapy of endometrial carcinoma]. Kanuma T; Matsuzawa M Gan No Rinsho; 1990 Aug; 36(10):1161-5. PubMed ID: 2214155 [TBL] [Abstract][Full Text] [Related]
37. Use of progestational agents in the management of metastatic carcinoma of the endometrium. Kistner RW; Griffiths CT Clin Obstet Gynecol; 1968 Jun; 11(2):439-56. PubMed ID: 4879374 [No Abstract] [Full Text] [Related]
38. 6-alpha-methyl- 17-alpha-hydroxyprogesterone acetate as a chemotherapeutic agent in adenocarcinoma of the uterus. Bonte JB; Drochmans A; Ide P Acta Obstet Gynecol Scand; 1966; 45(1):121-9. PubMed ID: 4160834 [No Abstract] [Full Text] [Related]
39. [Progestational hormones in the treatment of gynecologic cancers]. Soutoul JH; Lagabrielle V Presse Med (1893); 1969 Feb; 77(7):247-9. PubMed ID: 5795418 [No Abstract] [Full Text] [Related]